Rheumatology · Honolulu, HI
NPI
1558334888
Since 2006
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1329 Lusitana St Ste 206
Honolulu, HI, 96813
Phone (808) 528-3888
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.2M
425,826 services
Medicare patients, 2024
1,210
Average age 76
Drug cost, 2024
$2.1M
8,515 prescriptions
Company payments, 2025
$588
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ken C Arakawa was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 187,600 times for 49 patients. In total Ken C Arakawa billed 425,826 services in 76 codes, and Medicare paid $5.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 187,600 | 49 | $3.57 | $670K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 82,950 | 64 | $8.41 | $697K |
| J0897 Injection, denosumab, 1 mg | Office | 45,300 | 456 | $20.19 | $915K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 36,275 | 57 | $33.44 | $1.2M |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 19,711 | 176 | $0.10 | $1,980 |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,500 | 17 | $7.57 | $72K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,280 | 22 | $24.80 | $106K |
| J3245 Injection, tildrakizumab, 1 mg | Office | 3,600 | 11 | $105.62 | $380K |
| 96372 Injection Administration | Office | 2,516 | 557 | $11.65 | $29K |
| 99214 Office E&M - Established | Office | 2,320 | 838 | $87.32 | $203K |
| 36415 Venipuncture Blood Collection | Office | 1,116 | 422 | $8.38 | $9,348 |
| 82247 Clinical Chemistry | Office | 1,054 | 551 | $4.75 | $5,006 |
| 84295 Clinical Chemistry | Office | 1,053 | 551 | $4.55 | $4,790 |
| 84132 Clinical Chemistry | Office | 1,053 | 550 | $4.50 | $4,743 |
| 82565 Clinical Chemistry | Office | 1,053 | 550 | $4.85 | $5,110 |
By year: 2022 $3.5M for 217,620 services; 2023 $4.0M for 318,674 services; 2024 $5.2M for 425,826 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,116 | 422 | $8.38 | $9,348 |
| 82247 Clinical Chemistry | 1,054 | 551 | $4.75 | $5,006 |
| 84132 Clinical Chemistry | 1,053 | 550 | $4.50 | $4,743 |
| 82565 Clinical Chemistry | 1,053 | 550 | $4.85 | $5,110 |
| 84295 Clinical Chemistry | 1,053 | 551 | $4.55 | $4,790 |
| 84450 Clinical Chemistry | 1,052 | 550 | $4.91 | $5,166 |
| 84460 Clinical Chemistry | 1,052 | 550 | $5.02 | $5,278 |
| 86140 Clinical Chemistry | 997 | 518 | $4.92 | $4,903 |
| 85652 Clinical Chemistry | 997 | 518 | $2.57 | $2,558 |
| 85025 Blood Count | 986 | 516 | $7.36 | $7,260 |
Medicare prescription drug claims, 2024
In 2024, the drug Ken C Arakawa prescribed most often to Medicare patients was Prednisone, with 1,247 prescriptions and refills. In total Ken C Arakawa wrote 8,515 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,247 | 2,286 | 298 | $5,663 |
| Celecoxib Generic | 1,009 | 1,820 | 222 | $52K |
| Methotrexate Methotrexate Sodium | 964 | 2,297 | 243 | $36K |
| Meloxicam Generic | 896 | 1,611 | 219 | $8,938 |
| Hydroxychloroquine Sulfate Generic | 604 | 1,403 | 161 | $47K |
| Gabapentin Generic | 451 | 839 | 101 | $11K |
| Colchicine Generic | 263 | 624 | 76 | $16K |
| Duloxetine Hcl Generic | 254 | 531 | 68 | $16K |
| Alendronate Sodium Generic | 212 | 514 | 64 | $4,194 |
| Raloxifene Hcl Generic | 209 | 579 | 62 | $28K |
| Allopurinol Generic | 156 | 401 | 45 | $2,412 |
| Mycophenolate Mofetil Generic | 119 | 272 | 28 | $13K |
| Atorvastatin Calcium Generic | 111 | 334 | 38 | $3,467 |
| Folic Acid Generic | 96 | 237 | 27 | $1,038 |
| Omeprazole Generic | 85 | 248 | 27 | $3,228 |
Brand drugs: 444 claims; generic drugs: 8,071 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ken C Arakawa $588 ($588 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $395.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.